Diebold, Inc. (DBD) Tops Q2 EPS by 13c, Reaffirms FY11 Guidance
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $63.04 -2.1%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q2 EPS of $0.44, $0.13 better than the analyst estimate of $0.31. Revenue for the quarter came in at $662.4 million versus the consensus estimate of $655.93 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
